ArticleThe Journal of clinical investigation2020
TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis.
Eric Gracey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papercites it